CG Oncology (CGON) Institutional Ownership $33.47 +1.13 (+3.49%) (As of 11/22/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for CG Oncology (NASDAQ:CGON)CurrentInstitutional OwnershipPercentage26.56%Number ofInstitutional Buyers(last 12 months)45TotalInstitutional Inflows(last 12 months)$844.37MNumber ofInstitutional Sellers(last 12 months)11TotalInstitutional Outflows(last 12 months)$100.03M Get CGON Insider Trade Alerts Want to know when executives and insiders are buying or selling CG Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CGON Institutional Buying and Selling by Quarter Ad WealthPressI hate to say I told you soLast month, I openly declared that a Trump Presidency was going to kick off Tesla’s New Bullish Cycle Folks who listened and bought in when I said to are currently crushing it. As a matter of fact, all the trades we’ve opened ever since I made that public declaration have ALL been winners. And it’s simply because this Tesla indicator just flipped green on the stock…Follow this link right away. CG Oncology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/18/2024 Neo Ivy Capital Management29,678$1.12M0.4%N/A0.044% 11/16/2024 Geode Capital Management LLC1,078,527$40.70M0.0%+96.2%1.608% 11/15/2024 M&T Bank Corp16,758$632K0.0%+55.7%0.025% 11/15/2024 Barclays PLC90,520$3.42M0.0%+331.1%0.134% 11/15/2024 Jane Street Group LLC195,951$7.39M0.0%+240.5%0.292% 11/15/2024 Wellington Management Group LLP510,219$19.25M0.0%+153.4%0.761% Get the Latest News and Ratings for CGON and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CG Oncology and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024 State Street Corp1,700,653$64.17M0.0%+73.0%2.535% 11/15/2024 Point72 Asset Management L.P.746,063$28.15M0.1%+575.7%1.112% 11/15/2024 Polar Asset Management Partners Inc.25,800$973K0.0%N/A0.038% 11/15/2024 Janus Henderson Group PLC1,526,534$57.60M0.0%+7.0%2.276% 11/15/2024 HighVista Strategies LLC15,734$594K0.2%N/A0.023% 11/15/2024 ArrowMark Colorado Holdings LLC230,390$8.69M0.1%+17.4%0.343% 11/14/2024 Braidwell LP3,170,875$119.64M3.4%-4.2%4.727% 11/14/2024 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC21,122$797K0.0%-10.6%0.031% 11/14/2024 Ally Bridge Group NY LLC263,266$9.93M5.3%+50.5%0.392% 11/14/2024 Zurcher Kantonalbank Zurich Cantonalbank 6,399$241K0.0%N/A0.010% 11/14/2024 Yu Fan163,456$6.17M19.0%-89.6%0.244% 11/14/2024 ABG WTT Global Life Science Capital Partners GP Ltd495,526$18.70M92.9%-45.9%0.739% 11/14/2024 MetLife Investment Management LLC27,132$1.02M0.0%+103.2%0.040% 11/13/2024 BNP Paribas Financial Markets26,660$1.01M0.0%+876.9%0.040% 11/13/2024 FMR LLC145,606$5.49M0.0%+83,581.6%0.217% 11/13/2024 The Manufacturers Life Insurance Company 73,149$2.76M0.0%+21.3%0.109% 11/12/2024 Charles Schwab Investment Management Inc.379,664$14.33M0.0%+114.0%0.566% 11/12/2024 Massachusetts Financial Services Co. MA279,945$10.56M0.0%+4.9%0.417% 11/4/2024 Los Angeles Capital Management LLC22,052$832K0.0%N/A0.033% 11/4/2024 TimesSquare Capital Management LLC437,069$16.49M0.2%+27.4%0.652% 10/30/2024 Amalgamated Bank1,621$61K0.0%+107.6%0.002% 10/3/2024 SG Americas Securities LLC17,595$664K0.0%N/A0.026% 9/16/2024 Point72 Asia Singapore Pte. Ltd.1,209$38K0.0%-75.5%0.002% 8/19/2024 Point72 Asset Management L.P.110,410$3.49M0.0%-40.7%0.166% 8/16/2024 Perceptive Advisors LLC733,695$23.16M0.6%-43.7%1.101% 8/16/2024 Driehaus Capital Management LLC106,951$3.38M0.0%-0.9%0.160% 8/15/2024 Scientech Research LLC8,803$278K0.1%-27.8%0.013% 8/15/2024 The Manufacturers Life Insurance Company60,301$1.90M0.0%-5.4%0.090% 8/15/2024 Deerfield Management Company L.P. Series C433,540$13.69M0.2%+811.9%0.651% 8/15/2024 Point72 Asia Singapore Pte. Ltd.1,209$38K0.0%-75.5%0.002% 8/14/2024 Marshall Wace LLP75,982$2.40M0.0%N/A0.114% 8/14/2024 Yu Fan1,578,344$49.83M65.1%N/A2.368% 8/14/2024 Ally Bridge Group NY LLC174,876$5.52M3.3%-45.4%0.262% 8/14/2024 Profund Advisors LLC9,513$300K0.0%N/A0.014% [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin8/13/2024 Ensign Peak Advisors Inc60,565$1.91M0.0%N/A0.091% 8/9/2024 Renaissance Technologies LLC43,200$1.36M0.0%+204.2%0.065% 8/9/2024 Massachusetts Financial Services Co. MA266,787$8.42M0.0%+2.7%0.400% 8/3/2024 TD Asset Management Inc93,084$2.94M0.0%N/A0.140% 8/1/2024 Rhumbline Advisers34,229$1.08M0.0%+13.0%0.051% 7/26/2024 Bank of New York Mellon Corp89,344$2.82M0.0%+38.4%0.134% 5/17/2024 RA Capital Management L.P.1,397,433$61.35M0.8%N/A2.097% 5/16/2024 California State Teachers Retirement System2,341$103K0.0%N/A0.004% 5/16/2024 Janus Henderson Group PLC1,521,432$66.76M0.0%N/A2.283% 5/16/2024 BVF Inc. IL1,884,191$82.72M2.3%N/A2.827% 5/16/2024 Blackstone Inc.25,000$1.10M0.0%N/A0.038% 5/15/2024 Price T Rowe Associates Inc. MD992,118$43.56M0.0%N/A1.489% 5/15/2024 Avoro Capital Advisors LLC700,000$30.73M0.4%N/A1.050% 5/14/2024 StemPoint Capital LP40,723$1.79M0.5%N/A0.061% 5/14/2024 Decheng Capital LLC5,458,810$239.64M32.1%N/A8.191% 5/14/2024 American International Group Inc.306,226$13.44M0.0%N/A0.460% 5/13/2024 Ameritas Investment Partners Inc.2,320$102K0.0%N/A0.003% 5/10/2024 Vanguard Group Inc.2,225,018$97.68M0.0%N/A3.339% 5/7/2024 TimesSquare Capital Management LLC224,073$9.84M0.1%N/A0.336% 5/1/2024 Capstone Investment Advisors LLC18,354$806K0.0%N/A0.028% 5/1/2024 BNP Paribas Financial Markets11,198$492K0.0%N/A0.017% (Data available from 1/1/2016 forward) CGON Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CGON shares? During the previous two years, 52 institutional investors and hedge funds held shares of CG Oncology. The most heavily invested institutionals were Decheng Capital LLC ($239.64M), Braidwell LP ($119.64M), Vanguard Group Inc. ($97.68M), BVF Inc. IL ($82.72M), State Street Corp ($64.17M), RA Capital Management L.P. ($61.35M), and Janus Henderson Group PLC ($57.60M).Learn more on CGON's institutional investors. What percentage of CG Oncology stock is owned by institutional investors? 26.56% of CG Oncology stock is owned by institutional investors. Learn more on CGON's institutional investor holdings. Which institutional investors have been buying CG Oncology stock? Of the 45 institutional investors that purchased CG Oncology stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Decheng Capital LLC ($5.46M), Vanguard Group Inc. ($2.23M), BVF Inc. IL ($1.88M), Janus Henderson Group PLC ($1.62M), Yu Fan ($1.58M), RA Capital Management L.P. ($1.40M), and Price T Rowe Associates Inc. MD ($992.12K). How much institutional buying is happening at CG Oncology? Institutional investors have bought a total of 20,327,817 shares in the last 24 months. This purchase volume represents approximately $844.37M in transactions. Which CG Oncology major shareholders have been selling company stock? Of the 11 institutional investors that sold CG Oncology stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Yu Fan ($1.41M), Perceptive Advisors LLC ($570.41K), ABG WTT Global Life Science Capital Partners GP Ltd ($419.98K), Ally Bridge Group NY LLC ($145.50K), Braidwell LP ($138.63K), Point72 Asset Management L.P. ($75.83K), and Point72 Asia Singapore Pte. Ltd. ($7.45K). How much institutional selling is happening at CG Oncology? Institutional investors have sold a total of 2,783,055 shares in the last 24 months. This volume of shares sold represents approximately $100.03M in transactions. Related Companies Ascendis Pharma A/S Institutional Ownership Legend Biotech Institutional Ownership Elanco Animal Health Institutional Ownership Blueprint Medicines Institutional Ownership Lantheus Institutional Ownership Nuvalent Institutional Ownership Viking Therapeutics Institutional Ownership Cytokinetics Institutional Ownership TG Therapeutics Institutional Ownership Crinetics Pharmaceuticals Institutional Ownership This page (NASDAQ:CGON) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CG Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CG Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
